Search Within

Andrew D Zelenetz

Formats
  1. Meeting Abstract (461)
  2. Journal Article (288)
  3. Research Letter (14)
  4. Book Section (7)
  5. Guidelines (5)
  6. Conference Paper (3)
  7. Correspondence (3)
  8. Editorial (3)
  9. Review (1)
Groups
  1. Center for Hematologic Malignancies (785)
  2. Department of Medicine (785)
  3. Hematologic Malignancies, Division of (785)
  4. Lymphoma (785)
  5. Survivorship Research (234)
  6. Population Sciences Research Program (189)

More Groups

People
  1. Craig Moskowitz (207)
  2. Ariela Noy (188)
  3. Paul Hamlin (187)
  4. Steven Horwitz (169)
  5. David Straus (163)
  6. Maria Palomba (143)

More People

Years
  1. 2025 (8)
  2. 2024 (31)
  3. 2023 (43)
  4. 2022 (30)
  5. 2021 (29)
  6. 2020 (32)

More Years

Publications
  1. Blood (329)
  2. Journal of Clinical Oncology (83)
  3. Journal of the National Comprehensive Cancer Network (35)
  4. British Journal of Haematology (34)
  5. Leukemia and Lymphoma (31)
  6. Annals of Oncology (26)

More Publications

Publishers
  1. American Society of Hematology (341)
  2. American Society of Clinical Oncology (85)
  3. John Wiley & Sons (41)
  4. Harborside Press (35)
  5. Elsevier Inc. (31)
  6. Oxford University Press (31)

More Publishers

Results (785)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of the selective phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor idelalisib (GS-1101) in combination with rituximab (R) in treatment-naive patients (pts) ≥ 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
    Meeting Abstract

    O'Brien, S. M.; Lamanna, N.; Kipps, T. J.; Flinn, I.; Zelenetz, A. D.; Burger, J. A.; Holes, L.; Johnson, D. M.; Gu, J.; Dansey, R. D.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Medical oncologists' clinical experiences and comfort levels with 20 recently approved agents
    Meeting Abstract

    Love, N.; Anderson, K. C.; Flaherty, K.; Kantarjian, H. M.; Lynch, T. J.; O'Shaughnessy, J.; Sartor, A. O.; Venook, A. P.; Zelenetz, A. D.; Moss, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma
    Meeting Abstract

    Gerecitano, J. F.; Schwartz, G. K.; Carvajal, R.; Fury, M.; Konner, J.; Hyman, D. M.; Gounder, M.; Gajria, D.; Teitcher, J.; Zhang, Z.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • PET compared with CT as a prognosticator after rituximab induction therapy in follicular lymphoma: Report from the National Lymphocare Study
    Meeting Abstract

    Wong-Sefidan, I.; Byrtek, M.; Zhou, X.; Friedberg, J. W.; Flowers, C.; Link, B. K.; Zelenetz, A. D.; Dawson, K. L.; Reid, E. G.
    Blood (2013)

    Fulltext@MSK | Save
  • Cross-platform assessment of genomic imbalance in diffuse large B-cell lymphoma identifies novel candidate loci and genes with prognostic value and roles in lymphomagenesis
    Meeting Abstract

    Dias, L.; Thodima, V.; Mendiratta, G.; Asha, G.; Gonzalez, C.; Maragulia, J. C.; Zelenetz, A. D.; Feldstein, J. T.; Chaganti, R. S. K.; Houldsworth, J.
    Blood (2013)

    Fulltext@MSK | Save
  • Safety and efficacy of obinutuzumab (GA101) plus CHOP chemotherapy in first-line advanced diffuse large B-cell lymphoma: Results from the phase 2 gather study (GAO4915g)
    Meeting Abstract

    Zelenetz, A. D.; Mobasher, M.; Costa, L. J.; Flinn, I.; Flowers, C. R.; Kaminski, M. S.; Sandmann, T.; Trunzer, K.; Vignal, C.; Forero-Torres, A.
    Blood (2013)

    Fulltext@MSK | Save
  • FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • A proposed prognostic model for overall survival in the oldest old (>80 years old) follicular lymphoma patients
    Meeting Abstract

    Nabhan, C.; Byrtek, M.; Dawson, K. L.; Zhou, X.; Link, B. K.; Friedberg, J. W.; Zelenetz, A. D.; Cerhan, J. R.; Flowers, C. R.
    Blood (2013)

    Fulltext@MSK | Save
  • Excellent outcomes for limited-stage diffuse large B-cell lymphoma in the rituximab era: A retrospective analysis from Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Kumar, A.; Maragulia, J. C.; Lunning, M. A.; Moskowitz, C. H.; Zelenetz, A. D.
    Blood (2013)

    Fulltext@MSK | Save
  • Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform
    Meeting Abstract

    Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
    Blood (2013)

    Fulltext@MSK | Save